BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14959860)

  • 1. Hematological remission and long term hematological control of acute myeloblastic leukemia induced and maintained by granulocyte-colony stimulating factor (G-CSF) therapy.
    Xavier L; Cunha M; Gonçalves C; Teixeira Mdos A; Coutinho J; Ribeiro AC; Lima M
    Leuk Lymphoma; 2003 Dec; 44(12):2137-42. PubMed ID: 14959860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming and treatment with molgramostim (rhGM-CSF) in adult high-risk acute myeloid leukemia during induction chemotherapy: a prospective, randomized pilot study.
    Hansen PB; Johnsen HE; Jensen L; Gaarsdal E; Simonsen K; Ralfkiaer E
    Eur J Haematol; 1995 May; 54(5):296-303. PubMed ID: 7540147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission induction by granulocyte colony-stimulating factor in hypoplastic acute myelogenous leukemia complicated by infection. A case report and review of the literature.
    Takamatsu Y; Miyamoto T; Iwasaki H; Makino S; Tamura K
    Acta Haematol; 1998; 99(4):224-30. PubMed ID: 9644302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominance of myeloid antigens in CD34-positive peripheral blood stem cells over those in bone marrow after administration of granulocyte colony-stimulating factor.
    Fukuda T; Okamura S; Shimoda K; Takamatsu Y; Inaba S; Harada M; Niho Y
    Eur J Haematol; 1994 Apr; 52(4):201-6. PubMed ID: 7516293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human granulocyte colony-stimulating factor receptors in acute myelogenous leukemia.
    Kondo S; Okamura S; Asano Y; Harada M; Niho Y
    Eur J Haematol; 1991 Apr; 46(4):223-30. PubMed ID: 1707827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose dependent long-term in vivo remission of AML1/ETO positive acute myeloid leukemia with G-CSF.
    Zomas A; Stefanoudaki-Sofianatou K; Fisfis M; Anagnostopoulos NI
    Hematology; 2004 Apr; 9(2):107-11. PubMed ID: 15203865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition of CD13 and CD33 expression at relapse on acute myeloid leukemia cells with an unusual phenotype: MPO+CD13-CD33-.
    Kawada H; Ichikawa Y; Kobayashi N; Fukuda R; Yonekura S; Nagao T
    Intern Med; 1993 Sep; 32(9):733-6. PubMed ID: 7908235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful hematopoietic reconstitution with granulocyte colony-stimulating factor in a patient with hypoplastic acute myelogenous leukemia.
    Lee M; Chubachi A; Niitsu H; Miura I; Yanagisawa M; Hirokawa M; Miura AB
    Intern Med; 1995 Jul; 34(7):692-4. PubMed ID: 7496088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years.
    Candoni A; Martinelli G; Toffoletti E; Chiarvesio A; Tiribelli M; Malagola M; Piccaluga PP; Michelutti A; Simeone E; Damiani D; Russo D; Fanin R
    Leuk Res; 2008 Dec; 32(12):1800-8. PubMed ID: 18621416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte colony-stimulating factor receptor at various differentiation stages of normal and leukemic hematopoietic cells.
    Shinjo K; Takeshita A; Ohnishi K; Ohno R
    Leuk Lymphoma; 1997 Mar; 25(1-2):37-46. PubMed ID: 9130612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-CSF-induced remission in two cases of acute myeloid leukemia.
    Benz R; Goede JS; Parlier V; Mühlematter D; Jotterand M; Fehr J
    Leuk Res; 2008 Jul; 32(7):1148-52. PubMed ID: 18166225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complete remission in acute myeloblastic leukemia (M0) after treatment with rhG-CSF].
    Maeda A; Yoshinaga N; Hirata H; Asagoe K; Nohgawa M; Takano K; Harakawa N; Nakabo Y; Takahashi A; Yamamoto K
    Rinsho Ketsueki; 1995 Jan; 36(1):45-9. PubMed ID: 7536276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients.
    Suzuki T; Morio T; Tohda S; Nagata K; Yamashita Y; Imai Y; Aoki N; Hirashima K; Nara N
    Jpn J Cancer Res; 1990 Oct; 81(10):979-86. PubMed ID: 1699919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact on acute myeloid leukemia relapse in granulocyte colony-stimulating factor application: a meta-analysis.
    Feng X; Lan H; Ruan Y; Li C
    Hematology; 2018 Oct; 23(9):581-589. PubMed ID: 29516766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
    Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
    Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete remission in three patients with acute myeloblastic leukemia by administration of G-CSF without antileukemic agents.
    Takahashi M; Koike T; Aizawa Y; Kashimura M; Hayatsu K; Nagai K; Abe A; Urushiyama M; Yagisawa K
    Am J Hematol; 1997 Sep; 56(1):42-4. PubMed ID: 9298867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new bioassay for human granulocyte colony-stimulating factor (hG-CSF) using murine myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal healthy persons and patients with infectious and hematological disorders.
    Shirafuji N; Asano S; Matsuda S; Watari K; Takaku F; Nagata S
    Exp Hematol; 1989 Feb; 17(2):116-9. PubMed ID: 2463930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte colony-stimulating factor enhances the in vitro cytotoxicity of gemtuzumab ozogamicin against acute myeloid leukemia cell lines and primary blast cells.
    Rutella S; Bonanno G; Procoli A; Mariotti A; Lucia MB; Contemi AM; Cauda R; Fianchi L; Scambia G; Pagano L; Leone G
    Exp Hematol; 2006 Jan; 34(1):54-65. PubMed ID: 16413391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous transplantation in acute myeloid leukemia: peripheral blood stem cell harvest after mobilization in steady state by granulocyte colony-stimulating factor alone.
    Voog E; Le QH; Philip I; Benetaib B; Michallet M; Fiere D; Thomas X
    Ann Hematol; 2001 Oct; 80(10):584-91. PubMed ID: 11732869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutropenia-associated outcomes in adults with acute myeloid leukemia receiving cytarabine consolidation chemotherapy with or without granulocyte colony-stimulating factor.
    Bradley AM; Deal AM; Buie LW; van Deventer H
    Pharmacotherapy; 2012 Dec; 32(12):1070-7. PubMed ID: 23208834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.